Hingez Therapeutics LLC

UEI
KKTAV1ACNKA1
CAGE
7HAZ2
Primary NAICS
541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Subchapter S Corporation
  • Minority Owned Business
  • Subcontinent Asian (Asian-Indian) American Owned
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Small molecule inhibitors of PCSK9-phase II R44HL134462 National Heart Lung and Blood Institute (NIH) $1,964,245
Small molecule inhibitors of PCSK9 R43HL134462 National Institutes of Health $261,259

Quick answers

Is Hingez Therapeutics LLC registered in SAM.gov?

Hingez Therapeutics LLC's SAM.gov registration expired on October 16, 2026.

What is Hingez Therapeutics LLC's most recent federal award?

Hingez Therapeutics LLC's most recent federal grant award is Small molecule inhibitors of PCSK9-phase II (R44HL134462), from National Heart Lung and Blood Institute (NIH), on July 19, 2016.

On GovTribe

See Hingez Therapeutics LLC's full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login